The Center for Biotechnology has received a three-year, $500,000 U.S. Department of Commerce i6 Challenge Investment to support efforts to bolster the regional bioscience ecosystem.
Learn MoreDepYMed, a joint venture between Ohr Pharmaceutical, Inc. and Cold Spring Harbor Laboratory, has announced the completion of a Series ‘A’ Round of funding with TopSpin Fund, L.P. for a total of $2 million.
Learn MoreDon’t Miss the Life Sciences Summit 2016! Organized by the Center for Biotechnology and Demy-Colton, the Summit is an early stage investor and business development conference that highlights innovation. The objective of the event is to connect emerging biotech companies and academic innovators with the capital and strategic partners they will need to move new discoveries through clinical development.
Learn MoreStony Brook biotech company, Vitatex, has announced it was awarded an NCI Contract for Circulating Tumor Cell (CTC) Capture and Preservation Tubes.
Learn MoreThe Center for Biotechnology is thrilled to present our newly designed newsletter.
Learn MoreTraverse Biosciences and the Stony Brook University School of Dental Medicine have received a $1.3 million award from the National Institute of Dental and Craniofacial Research (NIDCR) of the National Institutes of Health (NIH) to further evaluate the pre-clinical safety and effectiveness of the Traverse Biosciences’ leading drug candidate,
Learn More